Cardiac Strains As a Tool for Optimization of Cardiac Resynchronization Therapy in Non-responders: a Pilot Study
Status PubMed-not-MEDLINE Jazyk angličtina Země Polsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
31934639
PubMed Central
PMC6947762
DOI
10.1515/med-2019-0111
PII: med-2019-0111
Knihovny.cz E-zdroje
- Klíčová slova
- Cardiac Resynchronization Therapy, Cardiac Strains, Heart Failure, Optimization, Speckle Tracking,
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Approximately 30% of patients do not respond to implantation of Cardiac Resynchronization Therapy - Defibrillators (CRT-D). The aim of this study was to investigate the potential for cardiac strain speckle tracking to optimize the performance of CRT-D in non-responding patients. METHODS: 30 patients not responding to Cardiac Resynchronization Therapy-Defibrillators after 3 months were randomly divided into control and intervention groups. Atrioventricular interval was adjusted so that E and A waves did not overlap, the interventricular interval was subsequently optimized to yield maximum improvement of the sum of longitudinal+radial+circumferential strains. The left ventricular ejection fraction (LVEF) and NYHA improvement 3 months after optimization were evaluated and use of other strain combinations assessed. RESULTS: A significant correlation between the (combined) strain change and LVEF improvement was detected (p<0.01). 75% of patients with non-ischemic etiology of heart failure who did not respond to the original CRT-D reacted favorably with significant LVEF and NYHA improvement. The area strain was the best predictor of LVEF/NYHA improvement in those patients. No significant improvement was recorded in patients with ischemic etiology. CONCLUSIONS: AV and VV optimization based on speckle tracking is a very promising method potentially leading to a significant improvement of the outcome of CRT-D, especially in patients with non-ischemic etiology of heart failure.
Clinic of Internal Medicine Cardiology University Hospital Brno 625 00 Czech Republic
Faculty of Medicine Masaryk University Brno Kamenice 5 625 00 Brno Czech Republic
Zobrazit více v PubMed
Marek J., Gandalovičová J., Kejřová E., Pšenička M., Linhart A., Paleček T.. Echocardiography and cardiac resynchronization therapy. Cor et Vasa. 2016;58(3):e340–e51.
Bax J.J., Marwick T.H., Molhoek S.G., Bleeker G.B., van Erven L., Boersma E.. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. The American journal of cardiology. 2003;92(10):1238–1240. et al. PubMed
Bax J.J., Gorcsan J.. 3rd, Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. Journal of the American College of Cardiology. 2009;53(21):1933–1943. PubMed
Ellenbogen K.A., Gold M.R., Meyer T.E., Fernndez Lozano I., Mittal S., Waggoner A.D.. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation. 2010;122(25):2660–2668. et al. PubMed
Daubert C., Behar N., Martins R.P., Mabo P., Leclercq C.. Avoiding non-responders to cardiac resynchronization therapy: a practical guide. European heart journal. 2017;38(19):1463–1472. PubMed
Chung E.S., Leon A.R., Tavazzi L., Sun J.P., Nihoyannopoulos P., Merlino J.. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117(20):2608–2616. et al. PubMed
McLeod C.J., Shen W.K., Rea R.F., Friedman P.A., Hayes D.L., Wokhlu A.. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy. Heart rhythm. 2011;8(3):377–382. et al. PubMed
Waggoner A.D., de las Fuentes L., Davila-Roman V.G.. Doppler echocardiographic methods for optimization of the atrioventricular delay during cardiac resynchronization therapy. Echocardiography (Mount Kisco, NY) 2008;25(9):1047–1055. PubMed PMC
Kutyifa V., Breithardt O.A.. How to assess the nonresponder to cardiac resynchronization therapy-a comprehensive stepwise approach. Revista espanola de cardiologia (English ed) 2012;65(6):504–510. PubMed
Suffoletto M.S., Dohi K., Cannesson M., Saba S., Gorcsan J.. 3rd, Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation. 2006;113(7):960–968. PubMed
Shah Amil M., Solomon Scott D.. Myocardial Deformation Imaging. Circulation. 2012;125(2):e244–e8. PubMed
Rizzello V., Poldermans D., Schinkel A.F.L., Biagini E., Boersma E., Elhendy A.. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart (British Cardiac Society) 2006;92(2):239–244. et al. PubMed PMC
Brignole M., Auricchio A., Baron-Esquivias G., Bordachar P., Boriani G., Breithardt O.A.. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC) Developed in collaboration with the European Heart Rhythm Association (EHRA), Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2013;2013;15(8):1070–1118. et al. PubMed
Ghio S., Freemantle N., Scelsi L., Serio A., Magrini G., Pasotti M.. Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. European journal of heart failure. 2009;11(5):480–488. et al. PubMed
Raatikainen M.J., Arnar D.O., Zeppenfeld K., Merino J.L., Levya F., Hindriks G.. Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2015:i1–75. et al. 17 Suppl 1. PubMed
Bozkurt B., Colvin M., Cook J., Cooper L.T., Deswal A., Fonarow G.C.. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation. 2016;134(23):e579–e646. et al. PubMed
Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L.. The effect of cardiac resynchronization on morbidity and mortality in heart failure. The New England journal of medicine. 2005;352(15):1539–1549. et al. PubMed